Resultados da busca - Nagahiro Saijo

Refinar Resultados
  1. 1
    Emerging ethnic differences in lung cancer therapy

    Emerging ethnic differences in lung cancer therapy por Ikuo Sekine, Noboru Yamamoto, Kazuto Nishio, Nagahiro Saijo

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Establishment of a human non‐small cell lung cancer cell line resistant to gefitinib

    Establishment of a human non‐small cell lung cancer cell line resistant to gefitinib por Fumiaki Koizumi, Tatsu Shimoyama, Fumiko Taguchi, Nagahiro Saijo, Kazuto Nishio

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Disparities in Cancer Care: A Worldwide Perspective and Roadmap for Change

    Disparities in Cancer Care: A Worldwide Perspective and Roadmap for Change por Olufunmilayo I. Olopade, Gilberto Schwartsmann, Nagahiro Saijo, Charles R. Thomas

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines

    Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines por Yu Kataoka, Toru Mukohara, Hiroyuki Shimada, Nagahiro Saijo, Mitsuharu Hirai, Hironobu Minami

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Small In-Frame Deletion in the Epidermal Growth Factor Receptor as a Target for ZD6474

    Small In-Frame Deletion in the Epidermal Growth Factor Receptor as a Target for ZD6474 por Tokuzo Arao, Hisao Fukumoto, Masayuki Takeda, Tomohide Tamura, Nagahiro Saijo, Kazuto Nishio

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway

    Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway por Kazuko Sakai, Hideyuki Yokote, Kimiko Murakami‐Murofushi, Tomohide Tamura, Nagahiro Saijo, Kazuto Nishio

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Antitumor activity of the selective epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI) Iressa® (ZD1839) in an EGFR‐expressing multidrug‐resistant cell line <i>in vitro</i> and <i>in vivo</i>

    Antitumor activity of the selective epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI) Iressa® (ZD1839) in an EGFR‐expressing multidrug‐resistant cell line <i>in... por Ichiro Naruse, Tohru Ohmori, Yoko Ao, Hisao Fukumoto, Toshio Kuroki, Masatomo Mori, Nagahiro Saijo, Kazuto Nishio

    Publicado em 2001
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study

    First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study por Seiji Niho, Kaoru Kubota, Kōichi Goto, Kiyotaka Yoh, Hironobu Ohmatsu, Ryutaro Kakinuma, Nagahiro Saijo, Yutaka Nishiwaki

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes

    Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes por S Niimi, Kei Nakagawa, Jun Yokota, Y Tsunokawa, Kazuto Nishio, Y Terashima, Masabumi Shibuya, M Terada, Nagahiro Saijo

    Publicado em 1991
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Osteopontin induces angiogenesis of murine neuroblastoma cells in mice

    Osteopontin induces angiogenesis of murine neuroblastoma cells in mice por Fumiyuki Takahashi, Shigeru Akutagawa, Hisao Fukumoto, Shoji Tsukiyama, Yuichiro Ohe, Kazuhisa Takahashi, Yoshinosuke Fukuchi, Nagahiro Saijo, Kazuto Nishio

    Publicado em 2002
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702

    Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer:... por Hiroaki Okamoto, Kenji Watanabe, Hiroshi Kunikane, Akira Yokoyama, S. Kudoh, T. Asakawa, Taro Shibata, Hideo Kunitoh, Tomohiro Tamura, Nagahiro Saijo

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib (“Iressa”) and the DNA topoisomerase I inhibitor CPT‐11 (irinotecan) in human colorectal cancer cells

    Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib (“Iressa”) and the DNA topoisomerase I inhibitor CPT‐11 (irinotecan) in human colorectal cancer cells... por Fumiaki Koizumi, Fumihiko Kanzawa, Yutaka Ueda, Yasuhiro Koh, Shoji Tsukiyama, Fumiko Taguchi, Tomohide Tamura, Nagahiro Saijo, Kazuto Nishio

    Publicado em 2003
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Highly Sensitive Detection of EGFR T790M Mutation Using Colony Hybridization Predicts Favorable Prognosis of Patients with Lung Cancer Harboring Activating EGFR Mutation

    Highly Sensitive Detection of EGFR T790M Mutation Using Colony Hybridization Predicts Favorable Prognosis of Patients with Lung Cancer Harboring Activating EGFR Mutation por Yoshihiko Fujita, Kenichi Suda, Hideharu Kimura, Kazuko Matsumoto, Tokuzo Arao, Tomoyuki Nagai, Nagahiro Saijo, Yasushi Yatabe, Tetsuya Mitsudomi, Kazuto Nishio

    Publicado em 2012
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)

    A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811) por Hideo Kunitoh, Tetsutaro Tamura, Taro Shibata, Michitaka Imai, Yutaka Nishiwaki, Makoto Nishio, Akira Yokoyama, Kenji Watanabe, K Noda, Nagahiro Saijo

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

    Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell l... por Yuichiro Ohe, Yasuo Ohashi, Kaoru Kubota, Tomohide Tamura, Kazuhiko Nakagawa, Shunichi Negoro, Yutaka Nishiwaki, Nagahiro Saijo, Y Ariyoshi, M. Fukuoka

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines.

    Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines. por Kei Nakagawa, Nagahiro Saijo, Shigeki Tsuchida, M Sakai, Y Tsunokawa, Jun Yokota, Masami Muramatsu, Kei Sato, M Terada, Kenneth D. Tew

    Publicado em 1990
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer

    Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer por Young Hak Kim, Genichiro Ishii, Kōichi Goto, Shuji Ota, Kaoru Kubota, Yukinori Murata, Michiaki Mishima, Nagahiro Saijo, Yutaka Nishiwaki, Atsushi Ochiai

    Publicado em 2008
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)

    A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group tri... por Hideo Kunitoh, Tomohide Tamura, Taro Shibata, Koji Takeda, Nobuyuki Katakami, Kazuhiko Nakagawa, Akira Yokoyama, Yutaka Nishiwaki, Kazumasa Noda, Kenji Watanabe, Nagahiro Saijo

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    LEVELS OF GLUTATHIONES TRANSFERASE π mRNA IN HUMAN LUNG CANCER CELL LINES CORRELATE WITH THE RESISTANCE TO CISPLATIN AND CARBOPLATIN

    LEVELS OF GLUTATHIONES TRANSFERASE π mRNA IN HUMAN LUNG CANCER CELL LINES CORRELATE WITH THE RESISTANCE TO CISPLATIN AND CARBOPLATIN por Kazuhiko Nakagawa, Jun Yokota, M Wada, Yasutsuna Sasaki, Yasuhiro Fujiwara, Masaharu Sakai, Masami Muramatsu, Takeo Terasaki, Y Tsunokawa, Masaaki Terada, Nagahiro Saijo

    Publicado em 1988
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice

    Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice por Yuichiro Ohe, Er Podack, K J Olsen, Yuki Miyahara, Koh Miura, Hitoshi Saitô, Yasuo Koishihara, Y Ohsugi, Tetsuya Ohira, Kazuto Nishio, Nagahiro Saijo

    Publicado em 1993
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: